Efficacy and Mechanism of NIV in Relieving Dyspnea After Exercise in Patients With Stable Severe COPD

Chronic Obstructive Pulmonary Disease Clinical Trial

Official title:

Efficacy and Mechanism of Non-invasive Ventilation in Relieving Dyspnea After Exercise in Patients With Stable Severe Chronic Obstructive Pulmonary Disease

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03568747
• Other study ID #: GIRD201801
• Status: Completed
• Phase: N/A
• Start date: June 23, 2018
• Est. completion date: April 30, 2019

Study information

• Verified date: June 2018
• Source: Guangzhou Institute of Respiratory Disease
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Exertional dyspnea is a major cause of exercise limitation and anxiety, and contributes importantly to reduced quality of life for patients with COPD. The aim of this study is to determine the efficacy and mechanism of NIV with a dual-limb circuit plus oxygen therapy in relieving exertional dyspnea in patients with severe COPD, so as to provide a guidance for clinical use for NIV.

Description:

Exertional dyspnea was the most characteristic respiratory symptoms in patients with chronic obstructive pulmonary disease (COPD), it is a major cause of exercise limitation and anxiety, and contributes importantly to reduced quality of life for patients with COPD. COPD patients often unconsciously adopt a sedentary lifestyle, probably due to distressing exertional dyspnea. The sedentarism results in physical deconditioning and alterations of the peripheral muscles, which leads to a vicious circle and contribute to the debilitation of the patients. Thereby, intervention should be taken to intervene this vicious cycle. It has been reported that noninvasive ventilation (NIV) could help unload the inspiratory muscle, improve dynamic pulmonary hyperinflation, improve neuro-mechanical coupling, oxygenation, and thus relieved dyspnea during exercise in COPD patients. However, in these reports, NIV was used as add-on therapy during exercise or at resting condition before exertional dyspnea occurred. So far, there's few studies on the efficacy of NIV used at the time of exertional dyspnea occurred as the rescue therapy to relieve dyspnea after exercise in patients with stable severe COPD while the patients are already undergoing optimal treatment with bronchodilator and anti-inflammatory medication, which might relieve their physiological and perceptional burden to limit their activities. The result of the investigators previous study has suggested that compared with oxygen therapy, NIV plus oxygen therapy resulted in decrease in dyspnea intensity at isotime, however, there's no statistically significant shortening in total dyspnea recovery time and NIV was not helpful in all the COPD patients. In another study, it was indicated that ventilated by a single-limb tubing with a plateau exhalation valve (PEV) caused CO2 rebreathing to COPD patients during exercise. CO2 rebreathing may have a negative impact on efficacy. Previous studies have proved that exercise tolerance was improved ventilated by noninvasive ventilation with a dual-limb circuit. In theory, NIV with a dual-limb circuit consists of one inhalation limb that introduces air into the patient's airways and one exhalation limb that leads exhaled gas outside of the airways, there is no risk of rebreathing. However, it is unclear whether NIV with a dual-limb circuit could be used at the time of exertional dyspnea occurred as rescue therapy to relieve dyspnea after exercise in patients with stable severe COPD and what are the mechanisms. The purpose of this study was therefore to determine whether assisted with NIV with dual-limb circuit in patients with stable severe COPD after exercise with exertional dyspnea (1)dyspnea was relieved after exercise in patients with stable severe COPD; (2)the repiratory mechanism.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 12
• Est. completion date: April 30, 2019
• Est. primary completion date: February 3, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 40 Years to 80 Years

Eligibility

Inclusion Criteria:

• severe COPD (post bronchodilator FEV1/FVC < 70% and FEV1 < 50% predicted)

• stable clinical condition(no exacerbation in the 4 weeks prior to study participation with no change in medications)

• dyspnea as a main symptom that limited daily activities

Exclusion Criteria:

• obvious pulmonary bullae demonstrated by chest CT scan or X-ray examination facial trauma/malformation; recent facial, upper airway or upper gastrointestinal tract surgery

• systolic blood pressure > 160mmHg or diastolic blood pressure > 100mmHg at rest

• unstable angina or a myocardial infarct in the previous four weeks

• resting sinus tachycardia ( > 120 beats/min)

• patients with musculoskeletal or neurological disorders

• patients who are unable to give informed consent

Related Conditions & MeSH terms

• Chronic Obstructive Pulmonary Disease
• Dyspnea
• Lung Diseases
• Lung Diseases, Obstructive
• Pulmonary Disease, Chronic Obstructive

Intervention

Device:
• noninvasive ventilation
dual-limb circuit NIV were given on maquet servo i apparatus
• oxygen therapy
oxygen therapy were introduced to the side port of the facemask

Locations

Country	Name	City	State
China	The First Affiliated Hospital of Guangzhou Medical University	Guangzhou	Guangdong

Sponsors (1)

Lead Sponsor	Collaborator
Guangzhou Institute of Respiratory Disease

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	change from baseline transdiaphragmatic pressure to complete recovery after exercise	Pdi	baseline, at peak exercise and at every 30s interval until complete recovery
Other	change from baseline esophageal pressure to complete recovery after exercise	Pes	baseline, at peak exercise and at every 30s interval until complete recovery
Other	change from baseline mouth pressure to complete recovery after exercise	Pm	baseline, at peak exercise and at every 30s interval until complete recovery
Other	change from baseline inspiratory capacity to complete recovery after exercise	IC	baseline, at peak exercise and at every 30s interval until complete recovery
Other	change from baseline minute ventilation to complete recovery after exercise	VE	baseline, at peak exercise and at every 30s interval until complete recovery
Other	change from baseline oxygen saturation to complete recovery after exercise	SpO2	baseline, at peak exercise and at every 30s interval until complete recovery
Other	change from baseline heart rate to complete recovery after exercise	HR	baseline, at peak exercise and at every 30s interval until complete recovery
Other	change from baseline total recovery time to complete recovery after exercise	total recovery time	baseline, at peak exercise and at every 30s interval until complete recovery
Other	change from baseline tidal volume to complete recovery after exercise	Vt	baseline, at peak exercise and at every 30s interval until complete recovery
Other	change from baseline respiratory rate to complete recovery after exercise	RR	baseline, at peak exercise and at every 30s interval until complete recovery
Other	change from baseline inspiratory time to complete recovery after exercise	Ti	baseline, at peak exercise and at every 30s interval until complete recovery
Other	change from baseline total duty cycle to complete recovery after exercise	Ttot	baseline, at peak exercise and at every 30s interval until complete recovery
Other	change from baseline expiratory time to complete recovery after exercise	Te	baseline, at peak exercise and at every 30s interval until complete recovery
Other	change from baseline pressure time product to complete recovery after exercise	PTP	baseline, at peak exercise and at every 30s interval until complete recovery
Primary	change from baseline Borg scale to complete recovery after exercise	this is a scale that asks the participants to rate the difficulty of breathing. It starts at number 0 where one's breathing is causing no difficulty at all and progresses through to number 10 where one's breathing difficulty is maximal.	baseline, at peak exercise and at every 30s interval until complete recovery
Secondary	change from baseline diaphragm electromyogram to complete recovery after exercise	EMGdi	baseline, at peak exercise and at every 30s interval until complete recovery
Secondary	change from baseline index of neuromechanical dissociation of the respiratory system to complete recovery after exercise	EMGdi%max:Vt%VCpred	baseline, at peak exercise and at every 30s interval until complete recovery